Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-18-005174
Filing Date
2018-03-21
Accepted
2018-03-21 16:41:49
Documents
98
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K sphs20171231_10k.htm 10-K 2466881
2 EXHIBIT 23.1 ex_107537.htm EX-23.1 3280
3 EXHIBIT 31.1 ex_107538.htm EX-31.1 13352
4 EXHIBIT 31.2 ex_107539.htm EX-31.2 14821
5 EXHIBIT 32.1 ex_107540.htm EX-32.1 8227
6 EXHIBIT 32.2 ex_107541.htm EX-32.2 9309
13 sphs20171231_10k.jpg GRAPHIC 34461
14 mechanism.jpg GRAPHIC 50460
15 topsalysin.jpg GRAPHIC 43370
  Complete submission text file 0001437749-18-005174.txt   9221808

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sphs-20171231.xml EX-101.INS 1871065
8 XBRL TAXONOMY EXTENSION SCHEMA sphs-20171231.xsd EX-101.SCH 83521
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sphs-20171231_cal.xml EX-101.CAL 45263
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sphs-20171231_def.xml EX-101.DEF 539272
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sphs-20171231_lab.xml EX-101.LAB 425943
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sphs-20171231_pre.xml EX-101.PRE 574297
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36054 | Film No.: 18704859
SIC: 2834 Pharmaceutical Preparations